KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $61,206,803 | +4.2% | 311,485 | +19.3% | 0.02% | -6.2% |
| Q3 2022 | $58,731,247 | +134.9% | 261,109 | +32.1% | 0.02% | +166.7% |
| Q2 2022 | $25,007,611 | -0.7% | 197,673 | -0.5% | 0.01% | +20.0% |
| Q1 2022 | $25,188,355 | -9.7% | 198,662 | -6.7% | 0.01% | -16.7% |
| Q4 2021 | $27,885,000 | +24.1% | 212,862 | +15.9% | 0.01% | +20.0% |
| Q3 2021 | $22,465,000 | +22.5% | 183,640 | +14.1% | 0.01% | +25.0% |
| Q2 2021 | $18,342,000 | +105.0% | 160,909 | +116.2% | 0.00% | +100.0% |
| Q1 2021 | $8,947,000 | -50.9% | 74,414 | -58.5% | 0.00% | -50.0% |
| Q4 2020 | $18,216,000 | +33.8% | 179,307 | +1.8% | 0.00% | 0.0% |
| Q3 2020 | $13,616,000 | +6708.0% | 176,094 | +1660.9% | 0.00% | – |
| Q2 2019 | $200,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |